Katharina Russo

Chief Financial Officer

Katharina has over 20 years of pharmaceutical experience in the US and globally and deep functional expertise across a broad spectrum of Finance topics.

Throughout her Finance career Katharina has focused on close enterprise collaboration to successfully execute market strategy, accelerate organic and inorganic growth and drive profit optimization.

In April 2023, Katharina joined Pharmacosmos Therapeutics as Chief Financial Officer. Previously she served as Head of FP&A for Novartis Corporation in the US.

Katharina holds a Master of Business Administration from the University of Economics and Business in Vienna, Austria.